Back to search

Ireland· IE-PA-PA23259/020/001

Minims Proxymetacaine hydrochloride 0.5% w/v, Eye Drops, Solution

A proxymetacaine product containing proxymetacaine hydrochloride, registered in Ireland by Bausch + Lomb Ireland Limited. The same ATC class is registered in 10 of our 19 countries.

ATC S01HA04

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedMinims Proxymetacaine hydrochloride 0…ATCS01HA04REGISTER NO.IE-PA-PA23259/020/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Proxymetacaine is registered in 10 of 19 countries.

Countries holding a registration under ATC S01HA04 (proxymetacaine), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 6 of them publish a price we can compare per daily dose

Proxymetacaine · ATC S01HA04

10 / 19 countries

  • Belgiumprice
  • Canada
  • Germany
  • Icelandprice
  • Ireland
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
PROXYMETACAINE HYDROCHLORIDE
Manufacturer
Bausch + Lomb Ireland Limited
Country
Ireland (IE)
ATC code
S01HA04
ATC class
Proxymetacaine
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA23259/020/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

20 interactions on record for proxymetacaine.

Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Proxymetacaine · interactions on record

20 records

  • 20 moderate

Most severe, free to view

  • MetoclopramideA03FA01moderate
  • SulfamethizoleB05CA04moderate
  • LidocaineC01BB01moderate
  • Silver sulfadiazineD06BA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Proxymetacaine in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All proxymetacaine products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Belgium · Alcaine
  • Bulgaria · Алкаин
  • Cyprus · Alcaine
  • Germany · Proparakain-Pos
  • United Kingdom (Northern Ireland) · Proxymetacaine Hydrochloride Minims Bausch & Lomb Uk
  • Greece · Alcaine
  • Iceland · Alcaine
  • Lithuania · Alcaine
  • Norway · Alcaine
  • Poland · Alcaine
  • Slovenia · Alcaine

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b1523371-2b06-422e-8501-e69de7b30af6
GET /v1/drugs/b1523371-2b06-422e-8501-e69de7b30af6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Eye drops, solution",
  "routes": [
    "Ocular use"
  ],
  "source": "hpra",
  "atc_all": [
    "S01HA",
    "S01HA04"
  ],
  "strength": null,
  "pa_number": "PA23259/020/001",
  "substances": [
    "PROXYMETACAINE HYDROCHLORIDE"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "09/03/2001",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about proxymetacaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.